Ulcerative Colitis

The doctor said that stress and diet had nothing to do with his condition, but every time he made a change in those departments he felt better and better until he decided to let his experience guide him.

Experience first led him to eat a diet devoid of meat or dairy, and to reduce stress by moving from the city to West Palm Beach.

In Florida he came across the Hippocrates Health Institute where he learned about the raw foods diet.

A raw diet is based on the principle that cooking food at temperatures more than 108 degrees Fahrenheit destroys nutrients and enzymes.

Enzymes help break down and unlock nutrients.

Not getting enough nutrients is what leads to overeating, one of the two biggest problems with health in our society, according to Nison.

"We overeat because we eat low quality food.

Eighty percent of our diet should be raw, fresh and organic.

The other 20 percent should have two of those things." Some ways to adhere to this diet are to juice fruits and vegetables, to make soups or smoothies with a blender, to dehydrate, and to simply eat combinations of uncooked ingredients.

Nison's third book is a compilation of recipes from raw foods proponents interviewed for book number two.

There are many other raw resources: "un"cookbooks and even restaurants.

...

Unlike self-administered therapies that require patients to inject themselves frequently, REMICADE is the only anti-TNF biologic administered directly by caregivers in the clinic or office setting.

In RA (3 mg/kg), CD (5 mg/kg), PsA (5 mg/kg), and UC (5 mg/kg), REMICADE is a two-hour infusion administered every 8 weeks, following a standard induction regimen that requires treatment at weeks 0, 2 and 6.

As a result, REMICADE patients may require as few as six treatments each year.

In AS (5 mg/kg), REMICADE is a two-hour infusion administered every 6 to 8 weeks, following a standard induction regimen that requires treatment at weeks 0, 2 and 6.

Centocor discovered REMICADE and has exclusive marketing rights to the product in the United States.

Schering-Plough markets REMICADE in all countries outside of the United States, except in Japan and parts of the Far East where Tanabe Seiyaku, Ltd.

markets the product and in China where Xian- Janssen markets REMICADE.

Important Safety Information Many people with heart failure should not take REMICADE; so prior to treatment you should discuss any heart condition with your doctor.

Tell your doctor right away if you develop new or worsening symptoms of heart...

[10] Grider JR, Foxx-Orenstein AE, Jin J-G.

5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat and guinea-pig intestine.

Gastroenterology 1998; 115:370-380.

[11] M�ller-Lissner SA, Fumagalli I, Bardhan KD, Pace F, Pecher E, Nault B, et al.

Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms of irritable bowel syndrome in patients with abdominal pain, bloating and constipation.

Aliment Pharacol Ther 2001;15:1655-1666 [12] Prather CM, Camilleri M, Zinsmeister AR, McKinzie S, Thomforde G.

Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome.

Gastroenterology 2000; 118:463-468.

[13] Coffin B, Farmachidi JP, Rueegg P, Bastie A, Bouhassira D.

Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects.

Aliment Pharmacol Ther 2003; 17:577-585.

[14] Lefkowitz M, Shi Y, Schmitt C, Krumholz S, Tanghe J.

The 5-HT4 partial agonist, tegaserod, improves abdominal discomfort/pain and normalizes altered bowel function in irritable bowel syndrome (IBS).

Am J Gastroenterol 1999; 94:266.

[15] Novick J, Miner P, Krause R, Glebas K, Bliesath H, Ligozio G et al.

A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation.

Aliment Pharmacol Ther 2002; 16:1877-1888.

[16] Kellow J, ...